Ealixir Statistics
Total Valuation
Ealixir has a market cap or net worth of $107.90 million. The enterprise value is -$141.54 million.
| Market Cap | 107.90M |
| Enterprise Value | -141.54M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Ealixir has 60.28 million shares outstanding.
| Shares Outstanding | 60.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.09% |
| Owned by Institutions (%) | n/a |
| Float | 18.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.83 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 14.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 133.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -84.78% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $577,722 |
| Profits Per Employee | -$17.49M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.23% in the last 52 weeks. The beta is 1.28, so Ealixir's price volatility has been higher than the market average.
| Beta (1Y) | 1.28 |
| 52-Week Price Change | -66.23% |
| 50-Day Moving Average | 1.78 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 55.51 |
| Average Volume (30 Days) | 540 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.20 |
Income Statement
In the last 12 months, Ealixir had revenue of $10.98 million and -$332.30 million in losses. Loss per share was -$0.97.
| Revenue | 10.98M |
| Gross Profit | n/a |
| Operating Income | -317.14M |
| Pretax Income | -330.14M |
| Net Income | -332.30M |
| EBITDA | -309.63M |
| EBIT | -316.02M |
| Loss Per Share | -$0.97 |
Balance Sheet
The company has $281.88 million in cash and $32.43 million in debt, giving a net cash position of $249.45 million or $4.14 per share.
| Cash & Cash Equivalents | 281.88M |
| Total Debt | 32.43M |
| Net Cash | 249.45M |
| Net Cash Per Share | $4.14 |
| Equity / Book Value | -1.43B |
| Book Value Per Share | -23.79 |
| Working Capital | 330.29M |
Cash Flow
In the last 12 months, operating cash flow was -$262.62 million and capital expenditures -$1.45 million, giving a free cash flow of -$219.21 million.
| Operating Cash Flow | -262.62M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | -219.21M |
| FCF Per Share | -$0.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,889.17% |
| Pretax Margin | -3,007.61% |
| Profit Margin | -3,027.34% |
| EBITDA Margin | -2,820.79% |
| EBIT Margin | -2,879.00% |
| FCF Margin | -1,997.08% |
Dividends & Yields
Ealixir does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -307.96% |
| FCF Yield | -203.16% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 8, 2020. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 8, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Ealixir has an Altman Z-Score of -5.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.45 |
| Piotroski F-Score | 1 |